Median Technologies SA (EPA:ALMDT)

Market Cap	115.65M
Revenue (ttm)	22.96M
Net Income (ttm)	-25.24M
Shares Out	34.89M
EPS (ttm)	-1.37
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	417,221
Average Volume	470,827
Open	3.300
Previous Close	3.315
Day's Range	3.105 - 3.495
52-Week Range	1.190 - 5.260
Beta	0.69
RSI	54.77
Earnings Date	Sep 16, 2025

About Median Technologies

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 225
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALMDT

Financial Performance

In 2024, Median Technologies's revenue was 22.96 million, an increase of 0.79% compared to the previous year's 22.78 million. Losses were -25.24 million, 9.83% more than in 2023.